Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Concord Medical Services ( (CCM) ) is now available.
On June 20, 2025, Concord Healthcare Group Co., Ltd., a subsidiary of Concord Medical Services, announced that its controlling shareholder, Beijing Concord Medical Technology Co., Ltd., sold 32,800,000 H shares of Concord Healthcare. This transaction, conducted at HK$6.12 per share, represents approximately 4.46% of the total issued shares, impacting the company’s shareholding structure.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Underperform.
The overall stock score for Concord Medical Services is significantly impacted by its poor financial performance, characterized by declining revenues, high leverage, and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield. These factors collectively contribute to a low overall stock score, highlighting considerable risk.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited operates in the healthcare industry, focusing on providing medical services and healthcare management. The company is involved in managing hospitals and clinics, and it has a market presence in China, with its subsidiary Concord Healthcare Group Co., Ltd. listed on the Hong Kong Stock Exchange.
Average Trading Volume: 33,185
Technical Sentiment Signal: Strong Sell
Current Market Cap: $25.51M
Find detailed analytics on CCM stock on TipRanks’ Stock Analysis page.